Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Nanexa via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-05-31 08:00:00
Nanexa AB (publ) today announces that the company has filed a complaint of patent infringement against the American company VitriVax Inc.
On May 27, 2021, Nanexa filed a complaint of patent infringement in the United States District Court of Delaware against VitriVax Inc. In the lawsuit, Nanexa has asserted three of its U.S. patents related to its drug delivery platform PharmaShell®. Nanexa seeks both damages and an injunction preventing VitriVax’s continued use of the technology.
"We are doing this to protect the significant investments we have made in our industry-leading technology," said David Westberg, CEO of Nanexa.